|1.||Cheng, Zhen: 5 articles (12/2010 - 02/2002)|
|2.||Quinn, Thomas P: 5 articles (07/2009 - 02/2002)|
|3.||Liu, Boli: 4 articles (08/2015 - 02/2008)|
|4.||Donnelly, Paul S: 3 articles (10/2015 - 02/2011)|
|5.||Wunderlich, Gerd: 3 articles (10/2015 - 05/2004)|
|6.||Cui, Mengchao: 3 articles (08/2015 - 07/2012)|
|7.||Collery, Philippe: 3 articles (08/2015 - 07/2007)|
|8.||Bao, Ande: 3 articles (12/2011 - 08/2010)|
|9.||Miao, Yubin: 3 articles (11/2007 - 02/2002)|
|10.||Welch, Michael J: 3 articles (11/2007 - 11/2003)|
01/01/2015 - "Rhenium 188 ((188)Re)-liposome, a nanoparticle undergoing clinical trials, emits gamma rays for imaging validation and beta rays for therapy, with biodistribution profiles preferential to tumors. "
11/01/2007 - "This study describes the development of biocompatible radioactive rhenium-loaded nanoparticles for radionuclide anti-cancer therapy. "
01/01/2015 - "Introduction of nanoliposomal forms of the rhenium cluster compound led to a practically normal morphological picture of bone marrow and increase of the RBC (by 60%) with normalization of hematocrit counts, and decrease of quantities of destructed RBC (3.2 times) in comparison with the tumor-bearing animals. "
03/21/2014 - "Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes."
07/01/2013 - "The latter was radiolabeled with (99m)Tc for imaging hypoxic regions of tumors and was characterized by means of its rhenium analogue. "
|2.||Hepatocellular Carcinoma (Hepatoma)
01/01/2014 - "The radio-isotope rhenium-labeled N-[2-(triphenylmethyl)thioethyl]-3-aza-19-ethyloxycarbonyl-3-[2-(triphenylmethyl)thioethyl] octadecanoate) ligand (188Re-MN-16ET) is a novel therapeutic agent under preclinical evaluation for hepatoma. "
04/01/1999 - "The aim of this study was to fully characterize newly developed radioactive rhenium glass microspheres in vivo by determining their biodistribution, stability, antitumor effect, and toxicity after hepatic arterial injection in a syngeneic rat hepatoma model. "
04/01/1999 - "Rhenium glass microspheres were made radioactive by neutron activation and then injected into the hepatic artery of Sprague-Dawley rats containing 1-week-old Novikoff hepatomas. "
09/01/2013 - "In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary results."
05/01/2007 - "To prospectively evaluate, in a multicenter clinical trial, dosimetry-guided transarterial radionuclide therapy (TART) with rhenium 188 ((188)Re) 4-hexadecyl 1,2,9,9-tetramethyl-4,7-diaza-1,10-decanethiol (HDD)-labeled iodized oil in inoperable hepatocellular carcinoma (HCC). "
03/01/2013 - "Long-term outcomes in haemophilic synovitis after radiosynovectomy using rhenium-186: a single-centre experience."
11/01/2007 - "The best treatment for synovitis in patients with inhibitors is radioactive synoviorthesis (rhenium for ankle and elbows, yttrium for knees). "
01/01/2011 - "colloidal preparations of 90-Yttrium, 186-Rhenium or 169-Erbium), is an approved, reliable and easily performed therapy for the treatment of chronic synovitis without harmful side effects. "
11/01/1994 - "We assessed the clinical results of 64 intraarticular injections of Yttrium 90 in the knee and 56 injections of Rhenium 186 in the wrist in 71 patients with RA, older than 40 years, without relief of synovitis after six months of systemic or local treatment and with a radiological stage I or II of their joints. "
07/01/2010 - "To evaluate the efficacy of beta-irradiation therapy with rhenium 188 ((188)Re) mercaptoacetyltriglycine (MAG3)-filled balloon dilation to prevent neointimal hyperplasia after stent placement in a canine iliac artery model. "
07/01/2010 - "Inhibition of neointimal hyperplasia after stent placement with rhenium 188-filled balloon dilation in a canine iliac artery model."
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|3.||pegylated liposomal doxorubicin
|5.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|4.||Heterologous Transplantation (Xenotransplantation)
|5.||Stem Cell Transplantation